Age-specific changes in obesity and associated cardiometabolic risk factors: a two-decade study of the Finnish adults
European Journal of Public Health · 01.02.2026 · 36 (1) · 162-168
DOI: 10.1093/eurpub/ckaf186 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, online erschienen am 18.11.2025. Verfasst von Annamari Lundqvist und 8 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Department, Finnish Institute for Health and Welfare, Helsinki, Finland. Hauptthemen laut MEDLINE: Obesity, Cardiometabolic Risk Factors, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk.
Abstract (Originalsprache)
We analyzed age-specific changes in obesity and associated cardiometabolic risk factors from 2000 to 2023 in Finland. The study is based on two cross-sectional health examination surveys in years 2000 and 2023, representing the Finnish adults (aged 30–64 years). Associations between obesity and cardiometabolic risk factors were assessed using age-adjusted logistic regression. From 2000 to 2023, the overall prevalence of obesity (BMI ≥30 kg/m2) increased from 21% to 30% in men, and from 22% to 30% in women. Class II-III obesity (BMI ≥35 kg/m2) doubled reaching 9.9% and 12.6% in men and women, respectively, in 2023. Most marked changes were observed in younger adults, among whom the obesity rates doubled, and class II–III obesity tripled. Obesity was strongly associated with other cardiometabolic risk factors in both 2000 and 2023. Over 90% of individuals with obesity had at least one associated cardiometabolic risk factor. In 2023, the age-adjusted odds of glucose metabolism abnormalities, hypertension, and dyslipidemia in individuals with obesity, compared to normal-weight individuals, were 5.67 (95% CI 3.24–9.94), and 6.52 (4.49–9.46), and 3.91 (2.52–6.06) in men, and 7.49 (3.09–18.13), and 4.79 (3.64–6.29) and 3.22 (2.23–4.64), in women, respectively. Obesity rates in Finland have increased significantly over the past two decades, especially in young adults. Given the persistent risk of cardiometabolic complications in individuals with obesity, the increasing obesity rates are projected to place a substantial public health burden. These findings underscore the urgent need for effective strategies to address the obesity epidemic and mitigate its health impacts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Public Health Department, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Novo Nordisk Farma Oy, Espoo, Finland.
ORCID-Profile: Tuija Jääskeläinen, Anniina Ojanen, Tarja Palosaari
Förderung
- Novo Nordisk
Zitieren
APA
Lundqvist, A., Jääskeläinen, T., Lehtoranta, L., Aspholm, S., Vessari, H., Ojanen, A., Palosaari, T., Cederberg-Tamminen, H., & Saukkonen, T. (2026). Age-specific changes in obesity and associated cardiometabolic risk factors: a two-decade study of the Finnish adults. European Journal of Public Health, 36(1), 162-168. https://doi.org/10.1093/eurpub/ckaf186
Vancouver
Lundqvist A, Jääskeläinen T, Lehtoranta L, Aspholm S, Vessari H, Ojanen A, et al. Age-specific changes in obesity and associated cardiometabolic risk factors: a two-decade study of the Finnish adults. European Journal of Public Health. 2026;36(1):162-168. doi:10.1093/eurpub/ckaf186
BibTeX
@article{Lundqvist2026,
author = {Lundqvist, Annamari and Jääskeläinen, Tuija and Lehtoranta, Lara and Aspholm, Susanna and Vessari, Hannu and Ojanen, Anniina and Palosaari, Tarja and Cederberg-Tamminen, Henna and Saukkonen, Tero},
title = {Age-specific changes in obesity and associated cardiometabolic risk factors: a two-decade study of the Finnish adults},
journal = {European Journal of Public Health},
year = {2026},
volume = {36},
number = {1},
pages = {162--168},
doi = {10.1093/eurpub/ckaf186}
}
EUVIMED